HUP0303132A2 - Szabályozó és kiegészítő HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és HIV által indukált antitestek detektálására szolgáló eljárás - Google Patents
Szabályozó és kiegészítő HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és HIV által indukált antitestek detektálására szolgáló eljárásInfo
- Publication number
- HUP0303132A2 HUP0303132A2 HU0303132A HUP0303132A HUP0303132A2 HU P0303132 A2 HUP0303132 A2 HU P0303132A2 HU 0303132 A HU0303132 A HU 0303132A HU P0303132 A HUP0303132 A HU P0303132A HU P0303132 A2 HUP0303132 A2 HU P0303132A2
- Authority
- HU
- Hungary
- Prior art keywords
- hiv
- antigens
- peptides
- antibodies induced
- detecting antibodies
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 230000001105 regulatory effect Effects 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 238000003018 immunoassay Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 101710150344 Protein Rev Proteins 0.000 abstract 1
- 101710149951 Protein Tat Proteins 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 108091005601 modified peptides Proteins 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
A találmány tárgyát képezik: - új és módosított peptidek, amelyekalapját HIV-szabályozó Tat- és Rev-fehérjéi és a Nef-kiegészítőfehérjéje képezik, és amelyek alkalmasak HIV-1-specifikus immunválaszkiváltására citotoxikus T-sejt-aktivitásra kifejtett antagonizálóhatás nélkül, valamint a fenti peptideket tartalmazó antigének, - azantigéneket tartalmazó vakcinakészítnények, - eljárás HIV vagy HIV-specifikus peptidek vagy fehérjék által indukált antitestektestfolyadék-mintában történő detektálására. A találmány alkalmazhatóa HIV diagnosztikájában és HIV-terápiás célokra. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20004412A NO314587B1 (no) | 2000-09-04 | 2000-09-04 | HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV |
| PCT/NO2001/000363 WO2002020555A2 (en) | 2000-09-04 | 2001-09-03 | Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0303132A2 true HUP0303132A2 (hu) | 2005-03-29 |
| HUP0303132A3 HUP0303132A3 (en) | 2012-09-28 |
Family
ID=19911532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0303132A HUP0303132A3 (en) | 2000-09-04 | 2001-09-03 | Hiv regulatory and auxiliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7097971B2 (hu) |
| EP (1) | EP1322666B1 (hu) |
| JP (1) | JP2004508382A (hu) |
| CN (2) | CN101628933A (hu) |
| AR (1) | AR033997A1 (hu) |
| AT (1) | ATE378350T1 (hu) |
| AU (2) | AU2001286336B2 (hu) |
| BR (1) | BR0114046A (hu) |
| CA (1) | CA2421199A1 (hu) |
| DE (1) | DE60131432T2 (hu) |
| EA (1) | EA006210B1 (hu) |
| ES (1) | ES2296793T3 (hu) |
| HU (1) | HUP0303132A3 (hu) |
| NO (1) | NO314587B1 (hu) |
| NZ (2) | NZ524557A (hu) |
| SK (1) | SK287913B6 (hu) |
| WO (1) | WO2002020555A2 (hu) |
| ZA (1) | ZA200301742B (hu) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2398816A1 (en) | 2000-02-04 | 2001-08-09 | Duke University | Human immunodeficiency virus vaccine |
| CA2645342A1 (en) | 2006-03-10 | 2007-09-20 | Peptcell Limited | Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof |
| JP4931483B2 (ja) * | 2006-06-14 | 2012-05-16 | ルネサスエレクトロニクス株式会社 | 半導体不良解析装置、不良解析方法、及び不良解析プログラム |
| ES2625406T3 (es) | 2010-03-25 | 2017-07-19 | Oregon Health & Science University | Glicoproteínas de CMV y vectores recombinantes |
| CN102210874A (zh) * | 2011-05-17 | 2011-10-12 | 浙江大学 | 一种hiv重组亚型dna疫苗的制备方法 |
| SI2691530T1 (en) | 2011-06-10 | 2018-08-31 | Oregon Health & Science University | CMV glycoproteins and recombinant vectors |
| US20130189754A1 (en) | 2011-09-12 | 2013-07-25 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
| US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
| IN2014KN02769A (hu) * | 2012-06-06 | 2015-05-08 | Bionor Immuno As | |
| EP2679596B1 (en) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 env glycoprotein variant |
| EP2928910B1 (en) * | 2012-12-06 | 2019-09-04 | PIN Pharma, Inc. | Treatment of inflammation, autoimmune, and neurodegenerative disorders with immunosuppressive tat derivative polypeptides |
| EP2848937A1 (en) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Methods of identifying novel HIV-1 immunogens |
| US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5219990A (en) * | 1991-01-28 | 1993-06-15 | Biogen, Inc. | Papillomavirus e2 trans-activation repressors |
| WO1994015634A1 (en) | 1992-12-30 | 1994-07-21 | Matthias Rath | Tat and rev oligopeptides in hiv treatment |
| EP0814834B2 (fr) * | 1995-03-08 | 2009-03-18 | Neovacs | Immunogenes denues de toxicite derivant d'une proteine de regulation retrovirale, anticorps diriges contre ces immunogenes, procede pour leur preparation et compositions pharmaceutiques les renfermant |
| US5891994A (en) * | 1997-07-11 | 1999-04-06 | Thymon L.L.C. | Methods and compositions for impairing multiplication of HIV-1 |
| IT1297090B1 (it) | 1997-12-01 | 1999-08-03 | Barbara Ensoli | Tat di hiv-1 o suoi derivati, da soli od in combinazione, a scopo vaccinale, profilattico e terapeutico, contro l'aids i tumori e le |
| FR2773156B1 (fr) * | 1997-12-26 | 2000-03-31 | Biovacs Inc | Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida |
| NO311807B1 (no) | 1999-03-04 | 2002-01-28 | Bionor Immuno As | HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV |
| AU4082300A (en) | 1999-06-21 | 2001-01-09 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Hiv tat peptides and multiple peptide conjugate system |
| SE0001351L (sv) * | 2000-04-12 | 2001-03-26 | Kjell Sjoegren | Smådjurstoalett |
-
2000
- 2000-09-04 NO NO20004412A patent/NO314587B1/no not_active IP Right Cessation
-
2001
- 2001-09-03 DE DE60131432T patent/DE60131432T2/de not_active Expired - Lifetime
- 2001-09-03 ES ES01965768T patent/ES2296793T3/es not_active Expired - Lifetime
- 2001-09-03 AU AU2001286336A patent/AU2001286336B2/en not_active Ceased
- 2001-09-03 EA EA200300335A patent/EA006210B1/ru not_active IP Right Cessation
- 2001-09-03 SK SK401-2003A patent/SK287913B6/sk not_active IP Right Cessation
- 2001-09-03 NZ NZ524557A patent/NZ524557A/en not_active IP Right Cessation
- 2001-09-03 AU AU8633601A patent/AU8633601A/xx active Pending
- 2001-09-03 AT AT01965768T patent/ATE378350T1/de not_active IP Right Cessation
- 2001-09-03 JP JP2002525175A patent/JP2004508382A/ja active Pending
- 2001-09-03 CN CN200910140941A patent/CN101628933A/zh active Pending
- 2001-09-03 CN CN01815739A patent/CN1458936A/zh active Pending
- 2001-09-03 NZ NZ535908A patent/NZ535908A/xx not_active IP Right Cessation
- 2001-09-03 EP EP01965768A patent/EP1322666B1/en not_active Expired - Lifetime
- 2001-09-03 HU HU0303132A patent/HUP0303132A3/hu unknown
- 2001-09-03 WO PCT/NO2001/000363 patent/WO2002020555A2/en active IP Right Grant
- 2001-09-03 US US10/129,333 patent/US7097971B2/en not_active Expired - Fee Related
- 2001-09-03 CA CA002421199A patent/CA2421199A1/en not_active Abandoned
- 2001-09-03 BR BR0114046-9A patent/BR0114046A/pt not_active IP Right Cessation
- 2001-09-04 AR ARP010104195A patent/AR033997A1/es active IP Right Grant
-
2003
- 2003-03-03 ZA ZA200301742A patent/ZA200301742B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0114046A (pt) | 2003-07-22 |
| CN1458936A (zh) | 2003-11-26 |
| DE60131432T2 (de) | 2008-09-18 |
| CA2421199A1 (en) | 2002-03-14 |
| WO2002020555A2 (en) | 2002-03-14 |
| JP2004508382A (ja) | 2004-03-18 |
| EA200300335A1 (ru) | 2003-08-28 |
| AU2001286336B2 (en) | 2007-03-15 |
| SK287913B6 (sk) | 2012-03-02 |
| ES2296793T3 (es) | 2008-05-01 |
| DE60131432D1 (de) | 2007-12-27 |
| EP1322666B1 (en) | 2007-11-14 |
| EP1322666A2 (en) | 2003-07-02 |
| SK4012003A3 (en) | 2003-09-11 |
| ZA200301742B (en) | 2004-06-21 |
| AU8633601A (en) | 2002-03-22 |
| WO2002020555A3 (en) | 2002-06-06 |
| NO20004412L (no) | 2002-03-05 |
| HUP0303132A3 (en) | 2012-09-28 |
| US7097971B2 (en) | 2006-08-29 |
| NZ535908A (en) | 2006-03-31 |
| EA006210B1 (ru) | 2005-10-27 |
| CN101628933A (zh) | 2010-01-20 |
| NO314587B1 (no) | 2003-04-14 |
| NO20004412D0 (no) | 2000-09-04 |
| ATE378350T1 (de) | 2007-11-15 |
| NZ524557A (en) | 2005-04-29 |
| AR033997A1 (es) | 2004-01-21 |
| US20050053616A1 (en) | 2005-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0303134A2 (hu) | HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és eljárás HIV által indukált antitestek detektálására | |
| HK1044778A1 (en) | Hiv-peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv hiv | |
| HUP0303132A2 (hu) | Szabályozó és kiegészítő HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és HIV által indukált antitestek detektálására szolgáló eljárás | |
| BR0210598A (pt) | Complexo solúvel que compreende uma glicoproteìna retroviral de superfìcie | |
| KR960703136A (ko) | 탠덤 합성 hiv-1 펩티드들 | |
| DE69737736D1 (de) | Induktion rev- und tat-spezifischer zytotoxischer t-zellen zur prävention und behandlung einer infektion durch humanen immundefizienz-virus (hiv) | |
| WO2001098460A3 (en) | Fusion proteins of mycobacterium tuberculosis | |
| EP1016671A3 (en) | Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) | |
| AU3972400A (en) | Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein | |
| PADBERG et al. | Recombinant polypeptides from the human immunodeficiency virus reverse transcriptase define three epitopes recognized by antibodies in sera from patients with acquired immunodeficiency syndrome | |
| Zuber et al. | Detection of macaque perforin expression and release by flow cytometry, immunohistochemistry, ELISA, and ELISpot | |
| WO1992022572A1 (en) | New hiv-1 gag and env peptides, diagnostic | |
| TH65071A (th) | เพพไทด์ควบคุม และอนุเคราะห์ hiv แอนติเจน องค์ประกอบวัคซีนชุดสำเร็จรูปอิมมูโนแอสเสย์และวิธีการของการตรวจหาแอนติบอดีที่ถูกชักนำโดย hiv | |
| Cosimi et al. | The characterization of HIV-1 specific CD4+ T helper epitopes | |
| FR2874017B1 (fr) | Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih | |
| Weber | Humoral immunity to the human immunodeficiency virus | |
| ATE434763T1 (de) | Verfahren zum nachweis des felinen immunschwächevirus | |
| DE3854665D1 (de) | Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern. | |
| Balachandra et al. | Characteristic of HIV-1 in V3 loop region based on seroreactivity and amino acid sequences in Thailand. | |
| Gnann Jr et al. | Designing Peptides to Immunologically Distinguish Specific Human Immunodeficiency Virus Isolates | |
| TH62264A (th) | Hiv เพพไทด์, แอนติเจน องค์ประกอบวัคซีน, ชุดสำเร็จรูปอิมมูโนแอสเสย์ และวิธีสำหรับตรวจหาแอนติบอดีที่ชักนำโดย hiv | |
| Human | JOHN W. GNANN, JR, AND MICHAEL BA OLDSTONE | |
| TH87273B (th) | วัคซีน | |
| TH87273A (th) | วัคซีน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |